Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BIOCRYST PHARMACEUTICALS INC | Chief Discovery Officer | Common Stock | 299K | $1.81M | $6.05 | Nov 14, 2022 | Direct |
BIOCRYST PHARMACEUTICALS INC | Chief Discovery Officer | Emp. Stock Option (Right to Buy) | 0 | Nov 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCRX | BIOCRYST PHARMACEUTICALS INC | Nov 14, 2022 | 5 | -$295K | 4 | Nov 16, 2022 | Chief Discovery Officer |
BCRX | BIOCRYST PHARMACEUTICALS INC | Mar 7, 2022 | 1 | -$343K | 4 | Mar 9, 2022 | Chief Discovery Officer |
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 14, 2021 | 2 | $0 | 4 | Dec 16, 2021 | Chief Discovery Officer |
BCRX | BIOCRYST PHARMACEUTICALS INC | Dec 7, 2021 | 3 | -$74K | 4 | Dec 9, 2021 | Chief Discovery Officer |